Based on recent data, AN2 Therapeutics, Inc. (ANTX) shows an Average True Range (ATR) of 0.06 and an Enterprise Value of 55.8M. Its average trading volume over the past 3 months is 1.53M, indicating liquidity. These fundamental metrics provide insight into ANTX's underlying financial health and market activity.
| ATR | 0.06 |
| Enterprise Value | 55.8M |
| Avg Vol (3 Months) | 1.53M |
| Avg Vol (10 Days) | 240.59K |
AN2 Therapeutics, Inc. (ANTX) technical indicators as of May 15, 2026: the SMA 20 is -1.3%, SMA 50 at -6.15%, and SMA 200 at -7.56%. The RSI 14 value is 45.06, suggesting its current momentum. These technical analysis signals help assess ANTX's price trends and potential future movements.
| SMA 20 | -1.3% |
| SMA 50 | -6.15% |
| SMA 200 | -7.56% |
| RSI 14 | 45.06 |
AN2 Therapeutics, Inc. (ANTX) stock performance overview as of May 15, 2026: The 52-week high is $6.91 (currently -31.61% below), and the 52-week low is $1 (currently 6% above). Over the past year, ANTX's performance is -7.09%, compared to the S&P 500's 12.09% change.
| 52-Week High | 6.91 |
| 52-Week High Chg | -31.61% |
| 52-Week Low | 1 |
| 52-Week Low Chg | +6.00% |
| S&P 500 52-Week Chg | 12.09% |
According to market data, AN2 Therapeutics, Inc. (ANTX) stock's recent performance metrics show that over the last month, ANTX is 4.42%, with a Year-to-Date (YTD) performance of 3.51%. Over the past year, the stock has seen a -7.09% change. These figures summarize ANTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 5 | 5.17 | 6.91 | 6.91 | 6.91 | 6.91 |
| Low | 3.94 | 2.93 | 1 | 1 | 1 | 1 |
| Performance | +3.51% | +4.42% | -0.84% | +4.42% | -7.09% | +3.51% |
According to current financial data, ANTX stock's P/E (TTM) ratio is -4.69, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ANTX, including P/S (N/A), P/B (1.98), and P/FCF (-4.17), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ANTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -4.69 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 1.98 | 3.79 | 13.84 | 4.67 |
| P/FCF (TTM) | -4.17 | 59.7 | -429.1 | 32.44 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep